Advanced Propolis Delivery: Strategies for Improved Bioavailability and Therapeutic Efficacy

Propolis, a natural resinous product of honeybees, exhibits a wide range of biological activities, including antimicrobial, anti-inflammatory, antioxidant, and antifungal effects. However, its clinical application is limited by poor water solubility, high viscosity, and low bioavailability. To address these challenges, advanced drug delivery systems (DDS) such as nanoparticles, liposomes, hydrogels, niosomes, and self-microemulsifying systems have been developed to enhance the stability, solubility, and targeted delivery of propolis and its bioactive compounds. Lipid-based carriers and nanostructured systems have demonstrated improved mucosal penetration, cellular uptake, and controlled release profiles, leading to enhanced therapeutic efficacy against pathogens, cancer cells, and inflammatory conditions. Propolis-based formulations have shown promising applications in wound healing, oral delivery, dermatology, metabolic disorders, and hair growth. Additionally, propolis has emerged as a functional carrier matrix in DDS, contributing both structural and therapeutic benefits. Computational modeling and novel formulation strategies further support the optimization of propolis-based systems. Despite these advancements, challenges remain regarding formulation stability, safety, and clinical validation, including concerns related to allergic reactions. Future perspectives highlight the importance of integrating propolis into sustainable, multifunctional DDS and adopting holistic, personalized treatment approaches supported by artificial intelligence. Overall, propolis represents a versatile and promising component in the development of next-generation drug-delivery platforms.